Please login to the form below

Not currently logged in


This page shows the latest Trodelvy news and features for those working in and with pharma, biotech and healthcare.

Gilead’s Trodelvy approved for triple-negative breast cancer in Europe

Gilead’s Trodelvy approved for triple-negative breast cancer in Europe

A month after receiving a positive opinion from the European Medicine Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP), Gilead Science’s Trodelvy (sacituzumab govitecan) has been approved ... The approval is based on results from

Latest news

More from news
Approximately 3 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company Events and Exhibition Stands is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...